Triggering of inflammasome by aggregated α–synuclein, an inflammatory response in synucleinopathies

G Codolo, N Plotegher, T Pozzobon, M Brucale… - PloS one, 2013 - journals.plos.org
Parkinson's disease (PD) is one of the most common neurodegenerative diseases. It is
characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta of …

Crosstalk between the NLRP3 inflammasome/ASC speck and amyloid protein aggregates drives disease progression in Alzheimer's and Parkinson's disease

J Hulse, K Bhaskar - Frontiers in Molecular Neuroscience, 2022 - frontiersin.org
Two key pathological hallmarks of neurodegenerative diseases, including Alzheimer's
disease (AD) and Parkinson's disease (PD), are the accumulation of misfolded protein …

Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and …

C Kim, B Spencer, E Rockenstein, H Yamakado… - Molecular …, 2018 - Springer
Background Synucleinopathies of the aging population are an heterogeneous group of
neurological disorders that includes Parkinson's disease (PD) and dementia with Lewy …

Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes

H Scheiblich, C Dansokho, D Mercan, SV Schmidt… - Cell, 2021 - cell.com
Microglia are the CNS resident immune cells that react to misfolded proteins through pattern
recognition receptor ligation and activation of inflammatory pathways. Here, we studied how …

Regulation of α-synuclein homeostasis and inflammasome activation by microglial autophagy

I Choi, GR Heaton, YK Lee, Z Yue - Science advances, 2022 - science.org
Autophagy clears protein aggregates, damaged cellular organelles, and pathogens through
the lysosome. Although autophagy is highly conserved across all cell types, its activity in …

Alpha-synuclein induced immune cells activation and associated therapy in Parkinson's disease

R Su, T Zhou - Frontiers in aging neuroscience, 2021 - frontiersin.org
Parkinson's disease (PD) is a neurodegenerative disorder closely related to immunity. An
important aspect of the pathogenesis of PD is the interaction between α-synuclein and a …

Inflammatory responses to monomeric and aggregated α-synuclein in peripheral blood of Parkinson disease patients

F Piancone, M Saresella, F La Rosa… - Frontiers in …, 2021 - frontiersin.org
To investigate whether different forms of α-synuclein (α-syn) proteins can induce
inflammation and activate the NLRP3 inflammasome, we stimulated with monomeric or …

Selective targeting of the TLR2/MyD88/NF-κB pathway reduces α-synuclein spreading in vitro and in vivo

D Dutta, M Jana, M Majumder, S Mondal, A Roy… - Nature …, 2021 - nature.com
Pathways to control the spreading of α-synuclein (α-syn) and associated neuropathology in
Parkinson's disease (PD), multiple system atrophy (MSA) and dementia with Lewy bodies …

Microglia‐specific knock‐out of NF‐κB/IKK2 increases the accumulation of misfolded α‐synuclein through the inhibition of p62/sequestosome‐1‐dependent …

SM Rocha, KS Kirkley, D Chatterjee, TA Aboellail… - Glia, 2023 - Wiley Online Library
Parkinson's disease (PD) is the most common neurodegenerative movement disorder
worldwide, with a greater prevalence in men than women. The etiology of PD is largely …

Nitrated α-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsets

AD Reynolds, DK Stone, RL Mosley… - The Journal of …, 2009 - journals.aai.org
Microglial inflammatory neuroregulatory activities affect the tempo of nigrostriatal
degeneration during Parkinson's disease (PD). Such activities are induced, in part, by …